The vascular effects of doxazosin in hypertension complicated by metabolic syndrome.

Abstract

AIMS To evaluate the vascular effects of doxazosin, an alpha-1 antagonist, in hypertensive patients with metabolic syndrome in whom the drug has previously been shown to exert beneficial metabolic actions on lipids and insulin metabolism. EXPERIMENTAL PROTOCOL Twelve untreated non-diabetic hypertensive patients with National Cholesterol Education Program (NCEP) ATP-III defined metabolic syndrome were assigned to three-months of treatment with doxazosin (5.5 +/- 1.9 mg/die). Study variables were measured at baseline and after treatment. End-points: forearm blood flow (strain-gauge plethysmography) responses to graded intra-arterial acetylcholine and sodium nitroprusside infusion to test endothelium-dependent and independent vasodilatation respectively. Minimum forearm vascular resistance, the ratio of mean blood pressure and post-ischaemic maximal blood flow, as an index of arteriolar structure; transcapillary albumin escape rate (the 1-h decay rate of I-albumin, 6-8 microC ev) as a measure of systemic capillary permeability. Lipids, fasting and post-glucose insulin were measured at baseline and after treatment. RESULTS Doxazosin reduced blood pressure, augmented acetylcholine-mediated vasodilatation, decreased minimum resistance and, although not to a statistically significant extent, transvascular albumin leakage increased high-density lipoprotein (HDL) cholesterol while triglycerides and post-stimulative hyperinsulinemia decreased. CONCLUSIONS Doxazosin improved endothelial-mediated vasomotor function and reversed abnormal arteriolar structure in hypertensive patients with metabolic syndrome while improving lipid profile and blunting post-glucose hyperinsulinemia.

Statistics

020040060020132014201520162017
Citations per Year

204 Citations

Semantic Scholar estimates that this publication has 204 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Dellomo2005TheVE, title={The vascular effects of doxazosin in hypertension complicated by metabolic syndrome.}, author={Giulia Dell'omo and Giuseppe Penno and Laura Pucci and Giovanni Pellegrini and Aurelio Scotti and Stefano Del Prato and Roberto Pedrinelli}, journal={Coronary artery disease}, year={2005}, volume={16 1}, pages={67-73} }